Identification of protein-protein interactions of human HtrA1.
暂无分享,去创建一个
A. Baldi | A. De Luca | M. G. Paggi | S. Toldo | L. Manente | M. Campioni | A. Severino | E. Spugnini | A. Vitiello | R. La Porta | Paola Fiore
[1] F. Segade. Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. , 2010, Gene.
[2] M. Caraglia,et al. The Serine Protease HtrA1 Specifically Interacts and Degrades the Tuberous Sclerosis Complex 2 Protein , 2010, Molecular Cancer Research.
[3] Y. Hathout,et al. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. , 2010, Investigative ophthalmology & visual science.
[4] Vasilis Vasiliou,et al. Evolutionary divergence and functions of the ADAM and ADAMTS gene families , 2009, Human Genomics.
[5] Juan Liu,et al. Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration. , 2009, Experimental eye research.
[6] C. Flannery,et al. 002 IDENTIFICATION OF A NOVEL HTRA1-SUSCEPTIBLE CLEAVAGE SITE IN HUMAN AGGRECAN: EVIDENCE FOR THE INVOLVEMENT OF HTRA1 IN AGGRECAN PROTEOLYSIS IN VIVO , 2009 .
[7] J. Chien,et al. HtrA serine proteases as potential therapeutic targets in cancer. , 2009, Current cancer drug targets.
[8] J. Chien,et al. Serine Protease HtrA1 Associates with Microtubules and Inhibits Cell Migration , 2009, Molecular and Cellular Biology.
[9] S. Abramson,et al. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin. , 2008, Osteoarthritis and cartilage.
[10] P. Visca,et al. The serine protease HtrA1 is a novel prognostic factor for human mesothelioma. , 2008, Pharmacogenomics.
[11] J. Emerich,et al. Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer. , 2008, Clinical biochemistry.
[12] R. Boot-Handford,et al. HtrA1 Inhibits Mineral Deposition by Osteoblasts , 2008, Journal of Biological Chemistry.
[13] E. Wylie,et al. HtrA1: a novel regulator of physiological and pathological matrix mineralization? , 2007, Biochemical Society transactions.
[14] W. Renner,et al. Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. , 2007, Molecular vision.
[15] Chi Pui Pang,et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.
[16] N. Camp,et al. A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.
[17] L. Salamonsen,et al. Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer. , 2006, Gynecologic oncology.
[18] B. Vincenzi,et al. Analysis of HtrA1 serine protease expression in human lung cancer. , 2006, Anticancer research.
[19] Alfonso Baldi,et al. Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. , 2006, The Journal of clinical investigation.
[20] W. Kong,et al. ADAMTS‐7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] Tim Clausen,et al. The Role of Human HtrA1 in Arthritic Disease* , 2006, Journal of Biological Chemistry.
[22] John T. Wei,et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. , 2005, Cancer cell.
[23] C. Gregory,et al. Increased expression of δ-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer , 2005 .
[24] M. Kawaichi,et al. Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis. , 2005, Bone.
[25] Alfonso Baldi,et al. Implications of the serine protease HtrA1 in amyloid precursor protein processing , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] Masato Yano,et al. Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. , 2004, The Biochemical journal.
[27] A. Baldi,et al. The Serine Protease HtrA1 Is Upregulated in the Human Placenta during Pregnancy , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[29] M. Kawaichi,et al. HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins , 2004, Development.
[30] David I. Smith,et al. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer , 2004, Oncogene.
[31] A. Baldi,et al. Distribution of the Serine Protease HtrA1 in Normal Human Tissues , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[32] L. Salamonsen,et al. Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. , 2003, The Biochemical journal.
[33] D. Noonan,et al. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells , 2002, Oncogene.
[34] C. Southan,et al. The HtrA family of proteases: implications for protein composition and cell fate. , 2002, Molecular cell.
[35] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[36] C. Southan,et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. , 2000, European journal of biochemistry.
[37] D. Kwiatkowski,et al. Molecular genetic advances in tuberous sclerosis , 2000, Human Genetics.
[38] K. Kosik,et al. δ‐catenin is a nervous system‐specific adherens junction protein which undergoes dynamic relocalization during development , 2000, The Journal of comparative neurology.
[39] C. Fusco,et al. Characterization of a Novel Human Serine Protease That Has Extensive Homology to Bacterial Heat Shock Endoprotease HtrA and Is Regulated by Kidney Ischemia* , 2000, The Journal of Biological Chemistry.
[40] C. Leonetti,et al. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] D. Luk,et al. Human HtrA, an Evolutionarily Conserved Serine Protease Identified as a Differentially Expressed Gene Product in Osteoarthritic Cartilage* , 1998, The Journal of Biological Chemistry.
[42] W. Franke,et al. Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family. , 1997, Differentiation; research in biological diversity.
[43] M. Lovett,et al. Presenilin 1 interaction in the brain with a novel member of the Armadillo family , 1997, Neuroreport.
[44] J. Zumbrunn,et al. Primary structure of a putative serine protease specific for IGF‐binding proteins , 1996, FEBS letters.
[45] A. Green,et al. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. , 1994, Human molecular genetics.
[46] A. Green,et al. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients , 1994, Nature Genetics.
[47] P. Byers,et al. Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern. , 1992, The Journal of biological chemistry.
[48] E. Ruoslahti,et al. Fibulin, a novel protein that interacts with the fibronectin receptor β subunit cytoplasmic domain , 1989, Cell.
[49] C. Georgopoulos,et al. Sequence analysis and regulation of the htrA gene of Escherichia coli: a sigma 32-independent mechanism of heat-inducible transcription. , 1988, Nucleic acids research.
[50] J. Beckwith,et al. An Escherichia coli mutation preventing degradation of abnormal periplasmic proteins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Baldi,et al. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. , 2009, Placenta.